Remedium Therapeutics

Remedium Therapeutics is an Indian drug development company focused on researching, developing, and manufacturing scientifically validated herbal and traditional Ayurvedic medicines. The company's lead product, CoroQuil-Zn, is an approved add-on therapy for mild-to-moderate COVID-19 and other respiratory ailments, developed in collaboration with Delhi Pharmaceutical Sciences and Research University (DPSRU). CoroQuil-Zn is formulated using edible plant extracts (such as willow bark) and zinc to support respiratory health, modulate immunity, and reduce inflammation. Remedium Therapeutics utilizes in silico molecular docking and cell-based studies to identify active phytoconstituents that target key disease pathways, such as the interaction between the SARS-CoV-2 spike protein and host ACE2 receptors.